Paxlovid
nirmatrelvir
ritonavir
COVID-19 virus infection
Date of authorisation:
Revision: 18
Last updated:
MedicineHumanAuthorised
Lopinavir/Ritonavir Mylan
lopinavir
ritonavir
HIV Infections
Date of authorisation:
Revision: 17
Last updated:
MedicineHumanAuthorised
Ritonavir Mylan
ritonavir
HIV Infections
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
Kaletra
lopinavir
ritonavir
HIV Infections
Date of authorisation:
Revision: 62
Last updated:
MedicineHumanAuthorised
Norvir
ritonavir
HIV Infections
Date of authorisation:
Revision: 70
Last updated:
MedicineHumanAuthorised
Aluvia
lopinavir
ritonavir
HIV Infections
Positive opinion
Opinion date:
Last updated:
EU-M4allHuman
EMEA-003081-PIP01-21-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0503/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Age-appropriate oral dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Viekirax
ombitasvir
paritaprevir
ritonavir
Hepatitis C, Chronic
Date of authorisation:
Revision: 28
Last updated:
MedicineHumanAuthorised
EMEA-002588-PIP01-19 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0396/2019
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman